October 14, 2019

Sun Pharmaceuticals Launches Cequa

Read More
October 14, 2019

Xarelto Receives New Indication

Read More
October 11, 2019

Reyvow Approved as First-in-Class Treatment for Migraines

Read More
October 10, 2019

Brand Medications with Generic Alternatives Anticipated to be Approved in November

Read More
October 8, 2019

Wilate Receives New Indications for Hemophilia A

Read More
October 8, 2019

Scenesse Approved to Reduce Pain of Protoporphyria

Read More
October 8, 2019

Beovu Approved to Treat Macular Degeneration

Read More
October 4, 2019

Aklief Approved to Treat Acne

Read More
October 4, 2019

Bonsity Approved to Treat Osteoporosis

Read More
October 4, 2019

Fasenra Approved for At-Home Administration

Read More
October 4, 2019

Quzyttir Approved to Treat Hives

Read More
October 3, 2019

Descovy Receives New Indication to Prevent HIV-1 Infection

Read More